Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOS2 | P35228 | 1/20 | 0.50 |
| ▸ | MAPK10 | P53779 | 1/20 | 0.44 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.41 |
| ▸ | PTGS1 | P23219 | 11/20 | 0.37 |
| ▸ | PTGS2 | P35354 | 5/20 | 0.35 |
| ▸ | JAK2 | O60674 | 1/20 | 0.35 |
| ▸ | RET | P07949 | 1/20 | 0.35 |
| ▸ | MAP2K1 | Q02750 | 1/20 | 0.35 |
| ▸ | MAP4K2 | Q12851 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12158615 | 0.83 | NOS2 (0.50) | NOS2MAPK10PTGS2MAP2K1MAP4K2 | |
| SCHEMBL16865684 | 0.83 | NOS2 (0.50) | NOS2MAPK10PTGS2MAP2K1MAP4K2 | |
| SCHEMBL17807492 | 0.83 | NOS2 (0.53) | NOS2MAPK10PTGS2MAP2K1MAP4K2 | |
| SCHEMBL31344191 | 0.83 | NOS2 (0.46) | NOS2 | |
| SCHEMBL20912486 | 0.81 | MAPK10 (0.49) | NOS2MAPK10MAPK14 | |
| SCHEMBL12158623 | 0.80 | NOS2 (0.46) | NOS2MAP2K1MAP4K2ALDH1A1LMNA | |
| SCHEMBL17807495 | 0.80 | NOS2 (0.46) | NOS2ALDH1A1 | |
| SCHEMBL16866585 | 0.75 | MAPK10 (0.49) | NOS2MAPK10ALDH1A1LMNA | |
| SCHEMBL12158625 | 0.73 | KDM4E (0.40) | NOS2MAPK14PTGS1PTGS2ALDH1A1 | |
| SCHEMBL4151921 | 0.71 | MAPK10 (0.41) | MAPK10MAPK14PTGS1PTGS2JAK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160164007-A1 | ORGANIC METAL COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE EMPLOYING THE SAME | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 2016-06-09 | — | — | US | disclosed |
| US-20160164007-A1 | ORGANIC METAL COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE EMPLOYING THE SAME | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 2016-06-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160164007-A1 | ORGANIC METAL COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE EMPLOYING THE SAME | C5, C9, C1S | NOS2 1101/4885MAPK10 2208/4885MAPK14 2414/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.